Commentary: novel delivery approaches for antiepileptic drugs: hope and hurdles.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

Corrections and comments

• Comment on
  Intraventricular and intracerebral delivery of anti-epileptic drugs in the kindling model.2009
• Comment on
  Convection-enhanced delivery in the treatment of epilepsy.2009
• Comment on
  Intranasal delivery of antiepileptic medications for treatment of seizures.2009
• Comment on
  Attenuation of kindled seizures by intranasal delivery of neuropeptide-loaded nanoparticles.2009
• Comment on
  Developing novel antiepileptic drugs: characterization of NAX 5055, a systemically-active galanin analog, in epilepsy models.2009

Authors and funding

2 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as